MarkADeegMDPhD, FNLA
Endocrinology • Indianapolis, INDiabetes, Lipid Metabolism, Clinical Pharmacology
EVP and Head of Global Clinical Development Cullgen Inc.
Dr. Deeg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Eli LIlly & Co.
Indianapolis, IN 46285Phone+1 317-277-9933- Is this information wrong?
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1992 - 1995
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1989 - 1992
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1988 - 1989
University of Minnesota Medical SchoolClass of 1988
Certifications & Licensure
IN State Medical License 1995 - 2025
Clinical Trials
- A Study of RG-012 in Subjects With Alport Syndrome Start of enrollment: 2017 Dec 22
Publications & Presentations
PubMed
- 1 citationsApplications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee os...Claire Smith, Y. Jin, Eyas Raddad, Terry A. McNearney, Xiao Ni, David Monteith, Roger Brown, Mark A. Deeg, Thomas J. Schnitzer> ;Pharmaceutical Statistics. 2019 Jan 1
- 30 citationsCGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial.Y. Jin, Claire Smith, David Monteith, R. Brown, A. Camporeale, Terry A. McNearney, Mark A. Deeg, Eyas Raddad, N. Xiao, A. de la Peña, Alan Kivitz, Thomas J. Schnitzer> ;Osteoarthritis and Cartilage. 2018 Dec 1
- 2 citationsEvaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabeti...Joanne Sloan-Lancaster, Eyas Raddad, Mark A. Deeg, Michelle Eli, Amy Flynt, James Tumlin> ;Clinical Pharmacology in Drug Development. 2018 Sep 1
- Join now to see all
Grant Support
- Effect Of Gemfibrozil On Gpi-Phospholipase D And TriglyceridesNational Center For Research Resources2007–2008
- Alcohol Effect On Serum ApolipoproteinsNational Institute On Alcohol Abuse And Alcoholism1998–2000
- Regulation And Function Of GPI Phospholipase DNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
- Regulation And Function Of GPI Phospholipase DNational Institute Of Diabetes And Digestive And Kidney Diseases1995
- Glycoinositol Phospholipid Metabolism In T LymphocytesNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
